Skip to main content
Have a personal or library account? Click to login
Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents Cover

Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents

Acta Pharmaceutica
Volume 66 (2016): Issue 2 (June 2016)
By: ,  ,  ,  ,   and    
Open Access
|May 2016
References

References

  1. 1. H. Frankish, 15 Million new cancer cases per year by 2020, says WHO,(2003) 1278–1287; DOI: 10.1016/S0140-6736(03)13038-3.
    Open DOISearch in Google Scholar
  2. 2. K. Kubo, T. Shimizu, S. I. Ohyama, H. Murooka, A. Iwai, K. Nakamura, K. Hasegawa, Y. Kobayashi, N. Takahashi, K. Takahashi, S. Kato, T. Izawa and T. Isoe, Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of-phenyl-’-{4-(4-quinolyloxy)phenyl}-ureas,.(2005) 1359–1366; DOI: 10.1021/jm030427r.
    Open DOISearch in Google Scholar
  3. 3. R. O’Connor, Mdm–mediated ubiquitylation: P53 and beyond, a review of mechanisms of circumvention and modulation of chemotherapeutic drug resistance,(2009) 273–280; DOI: 10.2174/156800909788166583.
    Open DOISearch in Google Scholar
  4. 4. C. Hu, V. R Solomon and G. L. Ulibarri, The efficacy and selectivity of tumor cell killing by AKT inhibitors are substantially increased by chloroquin,.(2008) 7888–7893; DOI: 10.1016/j.bmc.2008.07.076.
    Open DOISearch in Google Scholar
  5. 5. Y. C. Mayur, G. J. Peters, V. V. Prasad, C. Lemo and N. K. Sathish, Design of new drug molecules to be used in reversing multidrug resistance in cancer,(2009) 298–306; DOI: 10.2174/156800909788166619.
    Open DOISearch in Google Scholar
  6. 6. M. G. Ferlin, B. Gatto, G. Chiarelotto and M. Palumbo, Pyrroloquinoline derivatives as potential antineoplastic drugs,(2000) 1415–1422; DOI: 10.1016/S0968-0896(00)00060-2.
    Open DOISearch in Google Scholar
  7. 7. M. S. Alsaid, M. S. Bashandy, S. I. Al-Qasoumi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives,(2011) 137–141; DOI: 10.1016/j.ejmech.2010.10.024.
    Open DOISearch in Google Scholar
  8. 8. S. Pédeboscq, D. Gravier, F. Casadebaig, G. Hou, A. Gissot, F. De. Giorgi, F. Ichas, J. Cambar and J. P. Pometan, Synthesis and study of antiproliferative activity of novel thienopyrimidines on glioblastoma cells,(2010) 2473–2479; DOI:10.1016/j.ejmech.-2010.02.032.
    Search in Google Scholar
  9. 9. R. L. Weinkauf, A. Y. Chen, C. Yu, L. Liu, L. Barrows and E. J. LaVoie, Antineoplastic activity of benzimidazo[1,2-b] isoquinolines, indolo[2,3-b]quinolines, and pyridocarbazoles,(1994) 781–786; DOI: 10.1016/S0968-0896(00)82177-X.
    Open DOISearch in Google Scholar
  10. 10. S. Li, Z. Yao, Y. Zhao, W. Chen, H. Wang, X. Kuang, W. Zhan, S. Yao, S. Yu and W. Hu, Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase,.(2012) 5279–5282; DOI: 10.1016/j.bmcl.2012.06.044.
    Open DOISearch in Google Scholar
  11. 11. F. E. Onen-Bayram, I. Durmaz, D. Scherman, J. Herscovici and R. Cetin-Atalay, A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells,(2012) 5094–5102; DOI: 10.1016/j.bmc.2012.07.016.
    Open DOISearch in Google Scholar
  12. 12. G. J. Atwell, C. D. Bos, B. C. Baguley and W. A. Denny, Potential antitumor agents. 56. “Minimal” DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides,.(1988) 1048–1052; DOI: 10.1021/jm00400a029.
    Open DOISearch in Google Scholar
  13. 13. G. J. Atwell, B. C. Baguley and W. A. Denny, Potential antitumor agents. 57. 2-phenylquinoline-8-carboxamides as minimal DNA-intercalating antitumor agents with in vivo solid tumor activity,.(1989) 396–401; DOI: 10.1021/jm00122a018.
    Open DOISearch in Google Scholar
  14. 14. T. Suzuki, N. Fukazawa, K. San-nohe, W. Sato, O. Yano and T. Tsuruo, Structure activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer,.(1997) 2047–2052; DOI: 10.1021/jm960869l.
    Open DOISearch in Google Scholar
  15. 15. Y. H. Wang, T. Motoji, S. Motomura, N. Shiozaki, T. Tsuruo and H. Mizoguchi, Multi-drug resistance-reversing agent, on acute myelogenous leukaemic blasts and K562 cells resistant to adriamycin cell line,.(1997) 186–194; DOI: 10.1111/j.1600-0609.1997.tb00946.x.
    Open DOISearch in Google Scholar
  16. 16. H. Zhao, Y. Cai, S. Santi, R. Lafrenie and H. Lee, Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis,.(2005) 250–257; DOI: 10.1667/RR3436.1.
    Open DOISearch in Google Scholar
  17. 17. H. Zhang, V. R. Solomon, C. Hu, G. Ulibarri and H. Lee, Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives,(2008) 65–69; DOI: 10.1016/j.biopha.2007.04.007.
    Open DOISearch in Google Scholar
  18. 18. V. R. Solomon and H. Lee, Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies,.(2009) 220–233; DOI: 10.1016/j.ejphar.2009.06.063.
    Open DOISearch in Google Scholar
  19. 19. M. S. Al-Said, M. G. El-Gazzar, M. S. Al-Dosari and M. M. Ghorab, Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives,(2012) 149–156; DOI: 10.1055/s-0031-1299695.
    Open DOISearch in Google Scholar
  20. 20. P. Fossa, G. Menozzi, P. Dorigo, M. Floreani and L. Mosti, Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone,(2003) 4749–4759; DOI: 10.1016/S0968-0896(03)00528-5.
    Open DOISearch in Google Scholar
  21. 21. W. Chen, P. Zhan, D. Rai, E. De Clercq, C. Pannecouque, J. Balzarini, Z. Zhou, H. Liu and X. Liu, Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays,(2014) 1863–1872; DOI: 10.1016/j.bmc.2014.01.054.
    Open DOISearch in Google Scholar
  22. 22. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus,.(2013) 660–670; DOI: 10.1007/s12272-013-0094-6.
    Open DOISearch in Google Scholar
  23. 23. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid and M. Y. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents,.(2013) 50–58; DOI: 10.1248/cpb.c12-00812.
    Open DOISearch in Google Scholar
  24. 24. M. S. Alsaid, M. S. Bashandy and M. M. Ghorab, Novel quinolines bearing a biologically active trimethoxyphenyl moiety as a new class of antitumor agents,.(2011) 527–531; DOI: 10.1055/s-0031-1296239.
    Open DOISearch in Google Scholar
  25. 25. M. S. Bashandy, M. S. Al-Said, S. I. Al-Qasoumi and M. M. Ghorab, Design and synthesis of some novel hydrazide, 1, 2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity,.(2011) 521–526; DOI: 10.1055/s-0031-1296238.
    Open DOISearch in Google Scholar
  26. 26. M. M. Ghorab, M. S. Al-Said and E. M. El-Hossary,cytotoxic evaluation of some new heterocyclic sulfonamide derivatives,(2011) 563–571; DOI: 10.1002/jhet.619.
    Open DOISearch in Google Scholar
  27. 27. M. S. Al-Said, M. S. Bashandy, S. I. Al-Qasoumi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives,.(2011) 137–141; DOI: 10.1016/j.ejm-ech.2010.10.024.
    Search in Google Scholar
  28. 28. M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, Docking study, in vitro anticancer screening and radiosensitizing evaluation of some new fluorine-containing quinoline and pyrimidoquinoline derivatives bearing a sulfonamide moiety,(2011) 388–400; DOI: 10.1007/s00044-010-9332-3.
    Open DOISearch in Google Scholar
  29. 29. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening,.(1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.
    Open DOISearch in Google Scholar
  30. 30. M. M. Ghorab, M. S. Alsaid, H. A. Ghabour and H.-K. Fun, Synthesis, crystal structure and antitumor activity of novel 2-cyano--(quinolin-3-yl) acetamide,.(2014) 7389–7392; DOI:10.14233/ajchem.2014.17050.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/acph-2016-0016 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 155 - 171
Accepted on: Nov 5, 2015
Published on: May 28, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
quinolines,
pyridine,
thienopyridine,
isoquinoline,
acrylamide,
thiazole,
thiophene,
anticancer activity
Related subjects:
Pharmacy,
Pharmacy, other

© 2016 Mostafa M. Ghorab, Mansour S. Alsaid, Mohammed S. Al-Dosari, Fatma A. Ragab, Abdullah A. Al-Mishari, Abdulaziz N. Almoqbil, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 66 (2016): Issue 2 (June 2016)
Next article